|
|
|
|
|
Today's look at our PowerRatings Most Requested list yields two stocks that are far more likely than the average stock to be higher in a year's time. We can also use the Most Requested List to help us find a stock in the same industry as one of the more asked-about stocks that is probably a better bet than the requested stock in terms of being more reliable and a better performer after a year. First, let's look at the top PowerRatings stocks in today's list. One of those stocks is Charles River Laboratories (CRL | news | PowerRating | PR Charts ), which was our featured Stock Spotlight last week. Charles River Labs has a PowerRating of 10, the highest possible rating for a stock in our system. 10-rated stocks have been far more reliable investments than the average stock; based on our research going back to 1995, stocks with PowerRatings of 10 have been higher one year later more than 80% of the time. By comparison, the average stock has been higher one year later less than 68% of the time. Stocks with PowerRatings of 10 were also better performers than the average stock. While the average stock has tended to be higher by 12-13% after one year, 10-rated stocks have been higher one year later by more than 20% on average. Clearly when it comes to choosing stocks, 10-rated stocks represent far superior opportunities for investors compared to the average stock.
The other high PowerRating stock in today's Most Requested list is Procter & Gamble (PG | news | PowerRating | PR Charts ), with its PowerRating of 8. Although not as powerful in terms of reliability and performance as stocks with PowerRatings of 10, 8-rated stocks can be excellent additions to investment portfolios, as well. Reviewing thousands and thousands of simulated trades between 1995 and 2006, we discovered that stocks with PowerRatings of 8 were higher one year later more than 74% of the time. Moreoever, 8-rated stocks tended to average gains of more than 17% after one year.
The last stock I want to point out is Walgreens (WAG | news | PowerRating | PR Charts ). Walgreens was also in our Most Requested list as of this morning. But with a PowerRating of only 5, Walgreen's is not the sort of opportunity that investors should be considering right now. However, in the Drug Stores industry group that Walgreens belongs to, there is one stock -- Medco Health Solutions (MHS | news | PowerRating | PR Charts ) -- that investors should certainly pay more attention to. Medco Health Solutions -- which we own as part of our Live Blue Chip Porfolio -- is a stock with a PowerRating of 9, which means that it is more likely than Walgreens to be higher in a year's time. Stocks with PowerRatings of 9 have been higher one year later more than 79% of the time. 9-rated stocks are also superior performers compared to the average stock, averaging gains of more than 18% after one year.
Want to see the complete list of Most Requested stocks for today? Click here now.
Contact us Toll-free 1-888-358-1193 Outside the U.S. please call 1-201-680-7112
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Any information or material contained in the websites owned and operated by The Connors Group, Inc. (the "Company"), including but not limited to the THEFXMARKETS.COM, POWERRATINGS.NET, TRADINGMARKETS.COM, and THEMONEYBLOGS.COM websites (collectively, the "Websites"), and in the related services and products is provided for informational and educational purposes only. The information or material is NOT a recommendation or solicitation to buy or sell any security or other investment vehicle. Please review our full Disclaimer prior to using the Websites. Furthermore, your use of the Websites and all related services constitutes a legally binding agreement under the Company's terms and conditions. Please review the Terms and Conditions of Use. To better comprehend the Company's other practices and policies, please review the Privacy Policy and the Editorial Policy. Copyright © 2008 The Connors Group, Inc. |